Athira Pharma Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
LONA$4.47+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| ExhibitNumber | Description | Form | File No. | Exhibit | Filing Date |
| 3.1 | Amended and Restated Certificate of Incorporation of the Company | 10-Q | 001-39503 | 3.1 | November 12, 2020 |
| 3.2 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company dated May 23, 2024 | 8-K | 001-39503 | 3.1 | May 29, 2024 |
| 3.3 | Amended and Restated Bylaws of the Company | 8-K | 001-39503 | 3.1 | November 18, 2022 |
| 10.1** | Employment Offer Letter between the Company and Robert Renninger. | 8-K | 001-39503 | 10.1 | September 17, 2024 |
| 10.2** | Change in Control Agreement between the Company and Robert Renninger. | 8-K | 001-39503 | 10.2 | September 17, 2024 |
| 10.3†** | Separation Agreement and Release between Andrew Gengos and Athira Pharma, Inc. dated October 3, 2024. | 8-K | 001-39503 | 10.1 | October 7, 2024 |
| 10.4†** | Separation Agreement and Release between Rachel Lenington and Athira Pharma, Inc. dated October 1, 2024. | 8-K | 001-39503 | 10.2 | October 7, 2024 |
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2 | Certification of Principal Accounting and Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2* | Certification of Principal Accounting and Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | ||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and included in Exhibit 101) | ||||
- The certifications filed as Exhibits 32.1 and 32.2 are not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the Company under the Securities Exchange Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.
** Indicates a management contract or compensatory plan.
† Certain portions of this exhibit have been omitted because they are not material and is the type of information that the Company treats as private or confidential.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.